Minerva Advisors LLC lifted its stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 10.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,902 shares of the medical instruments supplier's stock after acquiring an additional 8,513 shares during the period. Utah Medical Products accounts for 3.1% of Minerva Advisors LLC's portfolio, making the stock its 8th largest position. Minerva Advisors LLC owned 2.65% of Utah Medical Products worth $4,870,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its position in shares of Utah Medical Products by 12.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 13,119 shares of the medical instruments supplier's stock worth $735,000 after acquiring an additional 1,421 shares in the last quarter. GAMMA Investing LLC grew its stake in Utah Medical Products by 134,400.0% during the 1st quarter. GAMMA Investing LLC now owns 4,035 shares of the medical instruments supplier's stock worth $226,000 after buying an additional 4,032 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Utah Medical Products by 14.8% in the fourth quarter. JPMorgan Chase & Co. now owns 79,703 shares of the medical instruments supplier's stock worth $4,899,000 after acquiring an additional 10,292 shares in the last quarter. Millennium Management LLC boosted its holdings in Utah Medical Products by 27.8% in the fourth quarter. Millennium Management LLC now owns 32,087 shares of the medical instruments supplier's stock worth $1,972,000 after acquiring an additional 6,975 shares in the last quarter. Finally, Northern Trust Corp raised its position in shares of Utah Medical Products by 5.1% in the 4th quarter. Northern Trust Corp now owns 36,832 shares of the medical instruments supplier's stock valued at $2,264,000 after purchasing an additional 1,773 shares during the last quarter. 69.60% of the stock is owned by institutional investors.
Utah Medical Products Stock Performance
UTMD stock traded down $0.65 during trading on Friday, reaching $54.95. The company had a trading volume of 14,304 shares, compared to its average volume of 13,457. The firm has a 50-day simple moving average of $56.15 and a 200-day simple moving average of $56.79. The company has a market cap of $178.59 million, a price-to-earnings ratio of 14.69 and a beta of 0.31. Utah Medical Products, Inc. has a twelve month low of $51.26 and a twelve month high of $69.30.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share for the quarter. The business had revenue of $9.95 million for the quarter. Utah Medical Products had a return on equity of 10.50% and a net margin of 32.34%.
Utah Medical Products Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Stockholders of record on Wednesday, September 17th will be paid a $0.305 dividend. The ex-dividend date is Wednesday, September 17th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.2%. Utah Medical Products's dividend payout ratio is presently 32.62%.
About Utah Medical Products
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles

Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.